416 related articles for article (PubMed ID: 31499172)
1. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.
Michaelis KA; Norgard MA; Levasseur PR; Olson B; Burfeind KG; Buenafe AC; Zhu X; Jeng S; McWeeney SK; Marks DL
Brain Behav Immun; 2019 Nov; 82():338-353. PubMed ID: 31499172
[TBL] [Abstract][Full Text] [Related]
2. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
3. Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology.
Baenziger S; Heikenwalder M; Johansen P; Schlaepfer E; Hofer U; Miller RC; Diemand S; Honda K; Kundig TM; Aguzzi A; Speck RF
Blood; 2009 Jan; 113(2):377-88. PubMed ID: 18824599
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.
Butchi NB; Pourciau S; Du M; Morgan TW; Peterson KE
J Immunol; 2008 Jun; 180(11):7604-12. PubMed ID: 18490763
[TBL] [Abstract][Full Text] [Related]
5. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
6. TLR4, TLR7/8 agonist-induced miR-146a promotes macrophage tolerance to MyD88-dependent TLR agonists.
Nahid MA; Benso LM; Shin JD; Mehmet H; Hicks A; Ramadas RA
J Leukoc Biol; 2016 Aug; 100(2):339-49. PubMed ID: 26908827
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
Rostamian M; Niknam HM
Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
[TBL] [Abstract][Full Text] [Related]
8. Identification, characterization and genetic mapping of TLR7, TLR8a1 and TLR8a2 genes in rainbow trout (Oncorhynchus mykiss).
Palti Y; Gahr SA; Purcell MK; Hadidi S; Rexroad CE; Wiens GD
Dev Comp Immunol; 2010 Feb; 34(2):219-33. PubMed ID: 19825389
[TBL] [Abstract][Full Text] [Related]
9. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod).
Jirmo AC; Daluege K; Happle C; Albrecht M; Dittrich AM; Busse M; Habener A; Skuljec J; Hansen G
J Immunol; 2016 Dec; 197(11):4219-4227. PubMed ID: 27799314
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens.
Philbin VJ; Iqbal M; Boyd Y; Goodchild MJ; Beal RK; Bumstead N; Young J; Smith AL
Immunology; 2005 Apr; 114(4):507-21. PubMed ID: 15804288
[TBL] [Abstract][Full Text] [Related]
11. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
[TBL] [Abstract][Full Text] [Related]
12. Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia.
Carroll JA; Race B; Williams K; Striebel JF; Chesebro B
J Neuroinflammation; 2021 Sep; 18(1):194. PubMed ID: 34488805
[TBL] [Abstract][Full Text] [Related]
13. Immune effects of R848: evidences that suggest an essential role of TLR7/8-induced, Myd88- and NF-κB-dependent signaling in the antiviral immunity of Japanese flounder (Paralichthys olivaceus).
Zhou ZX; Sun L
Dev Comp Immunol; 2015 Mar; 49(1):113-20. PubMed ID: 25475963
[TBL] [Abstract][Full Text] [Related]
14. Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug Vesicles.
Wang B; Van Herck S; Chen Y; Bai X; Zhong Z; Deswarte K; Lambrecht BN; Sanders NN; Lienenklaus S; Scheeren HW; David SA; Kiessling F; Lammers T; De Geest BG; Shi Y
J Am Chem Soc; 2020 Jul; 142(28):12133-12139. PubMed ID: 32524819
[TBL] [Abstract][Full Text] [Related]
15. Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance.
Bourquin C; Hotz C; Noerenberg D; Voelkl A; Heidegger S; Roetzer LC; Storch B; Sandholzer N; Wurzenberger C; Anz D; Endres S
Cancer Res; 2011 Aug; 71(15):5123-33. PubMed ID: 21697281
[TBL] [Abstract][Full Text] [Related]
16. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
17. Macrophage MMP10 Regulates TLR7-Mediated Tolerance.
Rohani MG; Dimitrova E; Beppu A; Wang Y; Jefferies CA; Parks WC
Front Immunol; 2018; 9():2817. PubMed ID: 30564235
[TBL] [Abstract][Full Text] [Related]
18. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
20. Low doses of LPS exacerbate the inflammatory response and trigger death on TLR3-primed human monocytes.
Monguió-Tortajada M; Franquesa M; Sarrias MR; Borràs FE
Cell Death Dis; 2018 May; 9(5):499. PubMed ID: 29717111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
